Global pharma industry facing uncertainty due to latest directive on drug pricing, impacting Indian drugmakers as well.Potential rise in medicine prices in other countries and implications on India-specific drug pricing discussed amid anticipated announcements.Trump's expectation of lowering drug prices for Americans by significant percentages poses questions on Indian drugmakers' positioning in the market.Pharmaceutical landscape set for recalibration with focus on trade negotiations, intellectual property rights, and impacts on generic drugs segment.